戻る Agenda
The Reality of Real-World Evidence – How Various Stakeholders Are Working With RWE to Improve Patient Outcomes
Session Chair(s)
June Raine, MD, MSC, FRCP
Chief Executive
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Real-world evidence (RWE) holds the potential to improve drug discovery and development, speed up access to market, improve patient care and make fok r more responsive and health care systems. The panel will discuss the progress being made to harness the use of RWE to improve patient outcomes and its practical implications. Session in development
Speaker(s)
Big Data and Personalised Medicine for Better Care Outcomes
Matej Adam
IBM Watson Health, Czech Republic
Business Development Executive Healthcare IT
Using the OMOP/OHDSI System for RWE with a Focus on the ‘E’ for Commercial and Non-Commercial Stakeholders
Christian G. Reich, DrMed
Nemesis Health , United States
Chief Science Officer
John Chisholm
Genomics England, United Kingdom